These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21437636)

  • 21. Multicentric Castleman's disease in a renal allograft recipient: a case report and literature review.
    Lin J; Yu S; Wang R; Chen J
    J Int Med Res; 2020 Feb; 48(2):300060519897481. PubMed ID: 32046545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orbital involvement in Castleman disease.
    Venizelos I; Papathomas TG; Papathanasiou M; Cheva A; Garypidou V; Coupland S
    Surv Ophthalmol; 2010; 55(3):247-55. PubMed ID: 20070998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.
    Basnayake BMDB; Wazil AWM; Kannangara T; Ratnatunga NVI; Hewamana S; Ameer AM
    J Med Case Rep; 2017 May; 11(1):135. PubMed ID: 28501028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-6-producing giant cell carcinoma of the lung with multicentric Castleman's disease-like presentation.
    Higashikuni Y; Mori M; Kino H
    Intern Med; 2007; 46(10):669-73. PubMed ID: 17527041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unicentric Castleman disease presenting as a retroperitoneal peripancreatic mass: A report of two cases and review of literature.
    Cheng JL; Cui J; Wang Y; Xu ZZ; Liu F; Liang SB; Tian H
    World J Gastroenterol; 2018 Sep; 24(34):3958-3964. PubMed ID: 30228787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Castleman disease presenting with ophthalmic signs and symptoms.
    Kurokawa T; Suzuki S; Kawaguchi K; Fujisawa N; Yoshimura N
    Am J Ophthalmol; 1999 Jul; 128(1):114-6. PubMed ID: 10482111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggressive angiofollicular lymph node hyperplasia (Castleman's disease) treated with high dose melphalan and autologous bone marrow transplantation.
    Repetto L; Jaiprakash MP; Selby PJ; Gusterson BA; Williams HJ; McElwain TJ
    Hematol Oncol; 1986; 4(3):213-7. PubMed ID: 3533746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical features of Castleman disease in the head and neck].
    Liu D; Sun F; Wei H; Wang J; Qian X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jul; 36(7):545-548. PubMed ID: 35822384
    [No Abstract]   [Full Text] [Related]  

  • 29. Widespread Castleman disease: CT findings.
    Gossios K; Nikolaides C; Bai M; Fountzilas G
    Eur Radiol; 1996; 6(1):95-8. PubMed ID: 8797962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemosiderin deposition in lymph nodes of patients with plasma cell-type Castleman disease.
    Han Y; Igawa T; Ogino K; Nishikori A; Gion Y; Yoshino T; Sato Y
    J Clin Exp Hematop; 2020 Mar; 60(1):1-6. PubMed ID: 32037354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unifocal cervical Castleman disease in two children.
    Tuerlinckx D; Bodart E; Delos M; Remacle M; Ninane J
    Eur J Pediatr; 1997 Sep; 156(9):701-3. PubMed ID: 9296533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature.
    Pan Y; Cui Z; Wang S; Zheng D; Deng Z; Tian X; Guo H; Bao W; Zhou S; Wang Y
    BMC Nephrol; 2020 Dec; 21(1):528. PubMed ID: 33276741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report.
    Li P; Liu H; Li H; Li A; Yu G; Yin W
    Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-6-positive classical Hodgkin's lymphoma co-occurring with plasma cell type of Castleman's disease: report of a case.
    Momoi A; Kojima M; Sakai T; Ajiro J; Isahai N; Nagai K; Aoki S
    Int J Hematol; 2013 Feb; 97(2):275-9. PubMed ID: 23359301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiopathic multicentric Castleman disease of TAFRO subtype.
    Godfrey K; Harris E; Moss H; Martin-Cabrera P
    Br J Haematol; 2022 Feb; 196(3):461. PubMed ID: 34618353
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis and Management of Castleman Disease.
    Abramson JS
    J Natl Compr Canc Netw; 2019 Nov; 17(11.5):1417-1419. PubMed ID: 31766018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five biopsies, one diagnosis: challenges in idiopathic multicentric Castleman disease.
    Semenchuk J; Merchant A; Sakhdari A; Kukreti V
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33229481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membranoproliferative glomerulonephritis associated with multicentric angiofollicular lymph node hyperplasia. Case report and review of the literature.
    Said R; Tarawneh M
    Am J Nephrol; 1992; 12(6):466-70. PubMed ID: 1292348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic Multicentric Castleman Disease with Cutaneous Manifestation: Case Report.
    Kosmidis CS; Mystakidou CM; Koimtzis G; Papadopoulou E; Theodorou V; Katsios NI; Georgakoudi E; Sevva C; Charalampous I; Varsamis N; Koulouris C; Michael C; Papadopoulos K; Anthimidis G; Baka S
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Castleman disease].
    Bleiber B; Gebbers JO; Joss R
    Med Klin (Munich); 2000 Sep; 95(9):527-32. PubMed ID: 11028170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.